Not a good buy right now for an impatient trader: the technical setup is still bearish/weak (below pivot, MACD negative), with no fresh news catalyst to force an immediate rebound.
Upside exists (UBS PT $55 vs. $48.99 pre-market) and fundamentals are improving, but the chart suggests waiting for confirmation (reclaiming ~$50.72 pivot) rather than buying into weakness.
Trend/structure: Price ($48.99 pre-market) is below the pivot (50.723), implying near-term downside pressure remains.
Momentum: MACD histogram at -0.438 and still below zero (bearish), though negatively contracting (selling pressure may be easing, but not reversed).
RSI: RSI(6)=41.7 (neutral-to-weak); not oversold enough to scream “must-buy,” but consistent with a soft/down tape.
Moving averages: Converging MAs = consolidation/indecision; needs a break above pivot to turn constructive.
Key levels:
Support: S1 47.17, then S2 44.98
Resistance: Pivot 50.72, then R1 54.28
Probabilistic pattern read: Similar-pattern tendency implies ~+1.54% next week but -2.78% next month, aligning with a choppy bounce risk inside a weaker broader setup.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Put/Call ratios are low (OI 0.4; Volume 0.44) → options flow/positioning skews bullish (more calls than puts).
Volatility: 30D IV 41.53 vs HV 29.3 and IV percentile 80 → options are pricing elevated uncertainty; typically better for sellers of premium than aggressive directional buyers.
Activity: Total volume is light (46 contracts), but today vs OI avg 30D ~110% suggests OI is relatively elevated versus its recent baseline (some positioning exists even if today’s prints are small).
Net read: Options sentiment leans bullish, but elevated IV implies the market is paying up for protection/convexity—consistent with uncertainty rather than a clean risk-on breakout.
Technical Summary
Sell
3
Buy
9
Positive Catalysts
showed broad-based improvement: revenue, EPS, net income, and gross margin all up YoY.
Neutral/Negative Catalysts
Technicals remain weak: below pivot, MACD negative, and no confirmed upside reversal yet.
UBS explicitly highlights tariff headwinds that may slow gross margin change and EPS growth.
No news in the last week → limited near-term event-driven fuel.
Similar-pattern forward tendency shows negative 1-month bias (-2.78%), increasing the risk that any bounce fades.
Growth profile: Healthy top-line growth with slightly improving margin suggests profitability is scaling with sales (constructive fundamental backdrop).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Latest update: UBS (2025-11-10) raised PT to $55 from $54, maintained Neutral.
Interpretation: Wall Street view is “stable but not compelling”—acknowledges improving sales trends but sees tariff/margin headwinds that could cap near-term upside.
Pros (Street): improving sales trajectory; PT implies upside from current levels.
Influential/political trading: No recent congress trading data available (no signal from politicians).
Wall Street analysts forecast BKE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BKE is 55 USD with a low forecast of 55 USD and a high forecast of 55 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast BKE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BKE is 55 USD with a low forecast of 55 USD and a high forecast of 55 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
Current: 50.880
Low
55
Averages
55
High
55
Current: 50.880
Low
55
Averages
55
High
55
UBS
Mauricio Serna
Neutral
maintain
$54 -> $55
AI Analysis
2025-11-10
Reason
UBS
Mauricio Serna
Price Target
$54 -> $55
AI Analysis
2025-11-10
maintain
Neutral
Reason
UBS analyst Mauricio Serna raised the firm's price target on The Buckle to $55 from $54 and keeps a Neutral rating on the shares. Tariff headwinds should cause Buckle's Q3 gross margin change and EPS growth to slow despite quarter over quarter sales growth acceleration, but this is likely already expected by the market, the analyst tells investors in a research note.
UBS
Neutral
maintain
$51 -> $54
2025-08-25
Reason
UBS
Price Target
$51 -> $54
2025-08-25
maintain
Neutral
Reason
UBS raised the firm's price target on The Buckle to $54 from $51 and keeps a Neutral rating on the shares post the Q2 report. The firm believes Buckle has a "solid playbook" to drive long-term sales growth but finds the stock fairly valued at current levels.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BKE
